A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...

According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo Fisher Scientific’s Ravi Gupta and Dr. Robert Balog.

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...

Genetic testing can help guide decisions about medical care by effectively diagnosing the disease and ensuring proper treatment. With Ubie's ability to reach patients before their diagnosis, genetic ...

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...